advertisement

---

Ophthalmologe 12

Showing records 1 to 12 | Display all abstracts in Ophthalmologe

91277 Preoperative management of subconjunctival/sub-Tenon's glaucoma surgery with special consideration of the gel implant (XEN®)
Erb C
Ophthalmologe 2021; 118: 139-143

---

91411 Treatment of secondary glaucoma following intravitreal anti-VEGF therapy with the XEN® gel stent and mitomycin C
Bedar MS
Ophthalmologe 2021; 118: 1128-1133

---

90911 Vasculat treatment concepts in glaucoma patients
Pillunat KR
Ophthalmologe 2021; 118: 431-438

---

90890 Risk factors for open-angle glaucoma and recommendations for glaucoma screening
Schuster AK
Ophthalmologe 2020; 117: 1149-1160

---

91674 Rho kinase inhibitors as new local therapy option in primary open angle glaucoma
Erb C
Ophthalmologe 2021; 118: 449-460

---

90890 Risk factors for open-angle glaucoma and recommendations for glaucoma screening
Wagner FM
Ophthalmologe 2020; 117: 1149-1160

---

91411 Treatment of secondary glaucoma following intravitreal anti-VEGF therapy with the XEN® gel stent and mitomycin C
Kellner U
Ophthalmologe 2021; 118: 1128-1133

---

91674 Rho kinase inhibitors as new local therapy option in primary open angle glaucoma
Konieczka K
Ophthalmologe 2021; 118: 449-460

---

90911 Vasculat treatment concepts in glaucoma patients
Pillunat LE
Ophthalmologe 2021; 118: 431-438

---

91277 Preoperative management of subconjunctival/sub-Tenon's glaucoma surgery with special consideration of the gel implant (XEN®)
Schargus M; Klabe K
Ophthalmologe 2021; 118: 139-143

---

90890 Risk factors for open-angle glaucoma and recommendations for glaucoma screening
Pfeiffer N; Hoff Mann EM
Ophthalmologe 2020; 117: 1149-1160

---

91277 Preoperative management of subconjunctival/sub-Tenon's glaucoma surgery with special consideration of the gel implant (XEN®)
Voykov B; Jünemann A
Ophthalmologe 2021; 118: 139-143

---